United States · Series B startup

Who invested in Jounce Therapeutics

2 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$103Mraised across 2 rounds since 2013, from 2 sources

$47MSeries A$56MSeries B
Latest round
Series B, $56MApr 2015
Investors
9
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201320142015
$47MSeries A$56MSeries B
First round
Series A, $47M
Feb 2013
Biggest round
$56M
Series B · Apr 2015
Between rounds
2.2 years
from the last two

The rounds

  1. Apr 2015
    Series B$56M8 new

    From a historical funding recordSEC filing: $56M sold, first sale Apr 2015

  2. Feb 2013
    Series A$47M1 new

    Reported by finsmes.com

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Cormorant Asset ManagementPrivate equity1round
Redmile GroupVC firm1round
Foresite CapitalPrivate equity1round
Casdin CapitalVC firm1round
Omega FundsVC firm1round
Third Rock VenturesVC firm1round
Nextech InvestPrivate equity1round
PharmstandardCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Jounce Therapeutics

Who invested in Jounce Therapeutics?

Jounce Therapeutics's investors include Wellington Management, Cormorant Asset Management, Redmile Group, Foresite Capital and Casdin Capital, and 4 more on record.

How much has Jounce Therapeutics raised?

Jounce Therapeutics has raised $103M across 2 rounds since 2013.

When did Jounce Therapeutics last raise?

Jounce Therapeutics's most recent round was a Series B of $56M in Apr 2015.

What was Jounce Therapeutics's biggest round?

Its most recent round, $56M in Apr 2015, is also its largest on record.

Who backed Jounce Therapeutics first?

Jounce Therapeutics's first round on record, in Feb 2013, was backed by Third Rock Ventures.

What stage is Jounce Therapeutics at?

Jounce Therapeutics's latest named round is a Series B, in Apr 2015.

Where is Jounce Therapeutics based?

Jounce Therapeutics is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.